Novartis announces option exercise and merger proposal

Novartis is to exercise its option to purchase the remaining shares in Alcon, Inc., owned by Nestle S.A. at a weighted average price of US$180 per share in cash following the agreement between Nestle and Novartis in April 2008.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.